Tryptase Enzyme Inhibiting Aminothiophenols
    1.
    发明申请
    Tryptase Enzyme Inhibiting Aminothiophenols 审中-公开
    胰蛋白酶抑制氨基噻酚

    公开(公告)号:US20100113608A1

    公开(公告)日:2010-05-06

    申请号:US12611239

    申请日:2009-11-03

    CPC分类号: C07C323/37

    摘要: Disclosed herein are novel compounds and pharmaceutical compositions comprising these compounds. In some embodiments, the compounds are inhibitors of the tryptase enzyme and are useful for treating allergic rhinitis, asthma, vascular injury (e.g., restenosis and atherosclerosis), inflammatory bowel disease, arthritis, psoriasis, anaphylaxis, wounds, infections, and other allergy and inflammatory related diseases.

    摘要翻译: 本文公开了包含这些化合物的新化合物和药物组合物。 在一些实施方案中,化合物是类胰蛋白酶的抑制剂,并且可用于治疗过敏性鼻炎,哮喘,血管损伤(例如再狭窄和动脉粥样硬化),炎性肠病,关节炎,牛皮癣,过敏反应,伤口,感染和其它过敏,以及 炎性相关疾病。

    Tryptase Enzyme Inhibiting Aminopyridines
    2.
    发明申请
    Tryptase Enzyme Inhibiting Aminopyridines 审中-公开
    胰蛋白酶抑制氨基吡啶类

    公开(公告)号:US20100113523A1

    公开(公告)日:2010-05-06

    申请号:US12608618

    申请日:2009-10-29

    CPC分类号: C07D213/74

    摘要: Disclosed herein are novel compounds and pharmaceutical compositions comprising these compounds. In some embodiments, the compounds are inhibitors of the tryptase enzyme and are useful for treating allergic rhinitis, asthma, vascular injury (e.g., restenosis and atherosclerosis), inflammatory bowel disease, arthritis, psoriasis, anaphylaxis, wounds, infections, and other allergy and inflammatory related diseases.

    摘要翻译: 本文公开了包含这些化合物的新化合物和药物组合物。 在一些实施方案中,化合物是类胰蛋白酶的抑制剂,并且可用于治疗过敏性鼻炎,哮喘,血管损伤(例如再狭窄和动脉粥样硬化),炎性肠病,关节炎,牛皮癣,过敏反应,伤口,感染和其它过敏,以及 炎性相关疾病。

    Extracts of Cranberry and Methods of Using Thereof
    4.
    发明申请
    Extracts of Cranberry and Methods of Using Thereof 审中-公开
    蔓越莓提取物及其使用方法

    公开(公告)号:US20100028469A1

    公开(公告)日:2010-02-04

    申请号:US12478431

    申请日:2009-06-04

    摘要: The present disclosure relates in part to extracts of cranberry (Vaccinium macrocarpon) comprising an enriched amount of certain compounds having anti-infective activity, e.g. antibacterial and/or antifungal activity, e.g. activity against C. albicans. Another aspect of the disclosure relates to combined cranberry and cinnamon extracts. In certain embodiments, these combined extracts have been optimized to control urinary tract infections caused by E. coli, S. aureus and C. albicans. Certain embodiments of the extract are enriched in bioactive compounds that have been shown to inhibit C. albicans adhesion and/or biofilm formation and its growth in vitro. In another aspect of the disclosure, the extracts are enriched in bioactives derived from cranberry and cinnamon that have been shown to inhibit the attachment and the growth of common urinary tract pathogens like E. coli, S. aureus and C. albicans.

    摘要翻译: 本公开部分涉及包含富集量的某些具有抗感染活性的化合物的蔓越莓(牛痘macrocarpon)的提取物。 抗菌和/或抗真菌活性,例如 针对白色念珠菌的活性。 本公开的另一方面涉及组合的蔓越莓和肉桂提取物。 在某些实施方案中,这些组合的提取物已被优化以控制由大肠杆菌,金黄色葡萄球菌和白色念珠菌引起的尿路感染。 提取物的某些实施方案富含生物活性化合物,其已被证明能抑制白色念珠菌粘附和/或生物膜形成及其体外生长。 在本公开的另一方面,提取物富含衍生自蔓越莓和肉桂的生物活性物质,其已被证明可抑制普通尿道病原体如大肠杆菌,金黄色葡萄球菌和白色念珠菌的附着和生长。

    Extracts of Curcuma and Methods of Use Thereof
    10.
    发明申请
    Extracts of Curcuma and Methods of Use Thereof 审中-公开
    姜黄提取物及其使用方法

    公开(公告)号:US20100098788A1

    公开(公告)日:2010-04-22

    申请号:US12580778

    申请日:2009-10-16

    CPC分类号: A61K36/9066

    摘要: The present invention relates in part to turmeric extracts that are useful for treating or preventing neurodegenerative disorders. Another aspect of the invention relates in part to turmeric extracts that are useful for treating or preventing inflammatory disorders. In some embodiments, the extracts comprise at least one compound selected from the group consisting of 25 to 500 μg bamosamine, 25 to 750 μg echinaxanthol, 100 to 3,000 μg bisdemethoxycurcumin, 50 to 500 μg daphniyunnine E and 500 to 75,000 μg curcumin per 100 mg of extract. Another aspect of the invention relates to pharmaceutical compositions comprising the aforementioned extracts. Another aspect of the invention relates to methods of treating or preventing neurodegenerative disorders comprising administering to a subject in need thereof an effective amount of the aforementioned extracts or compositions. Another aspect of the invention relates to methods of making the aforementioned extracts.

    摘要翻译: 本发明部分涉及可用于治疗或预防神经变性疾病的姜黄提取物。 本发明的另一方面部分涉及可用于治疗或预防炎症性疾病的姜黄提取物。 在一些实施方案中,所述提取物包含至少一种选自25至500μg苯巴胺,25至750μg依普潘醇,100至3,000μg双甲氧基姜黄素,50至500μg达芬尼林E和500至75,000μg姜黄素/ 100mg的化合物 的提取物。 本发明的另一方面涉及包含上述提取物的药物组合物。 本发明的另一方面涉及治疗或预防神经变性疾病的方法,包括向有需要的受试者施用有效量的上述提取物或组合物。 本发明的另一方面涉及制备上述提取物的方法。